A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma
- 31 May 2000
- journal article
- clinical trial
- Published by Elsevier BV in European Journal of Cancer
- Vol. 36 (8), 1016-1025
- https://doi.org/10.1016/s0959-8049(00)00072-1
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Treatment of Advanced Pancreatic Adenocarcinoma with 5-FU, Leucovorin, Interferon-α-2b, and CisplatinAmerican Journal of Clinical Oncology, 1997
- Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinomaCancer, 1996
- Phase II study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinomaAnnals of Oncology, 1993
- Phase II evaluation of fluorouracil and recombinant α-2a-interferon in previously untreated patients with pancreatic adenocarcinomaCancer, 1992
- A phase III trial on the therapy of advanced pancreatic carcinoma evaluations of the mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatinCancer, 1990
- Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.Journal of Clinical Oncology, 1986
- Chemotherapy for advanced pancreatic cancer.A comparison of 5-fluorouracil, adriamycin, and mitomycin (fam) with 5-fluorouracil, streptozotocin, and mitomycin (fsm)Cancer, 1986
- 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreasCancer, 1980
- Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancerCancer, 1978
- Use of 5-Fluorouracil in Disseminated Solid NeoplasmsAnnals of Surgery, 1962